Compare ALT & SVC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ALT | SVC |
|---|---|---|
| Founded | 1997 | 1995 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 415.3M | 380.4M |
| IPO Year | N/A | N/A |
| Metric | ALT | SVC |
|---|---|---|
| Price | $3.61 | $1.79 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 7 | 2 |
| Target Price | ★ $16.33 | $2.75 |
| AVG Volume (30 Days) | ★ 4.8M | 1.1M |
| Earning Date | 11-06-2025 | 11-05-2025 |
| Dividend Yield | N/A | ★ 2.30% |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $20,000.00 | ★ $1,873,944,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $2.90 | $1.55 |
| 52 Week High | $7.83 | $3.08 |
| Indicator | ALT | SVC |
|---|---|---|
| Relative Strength Index (RSI) | 31.65 | 43.73 |
| Support Level | $3.83 | $1.66 |
| Resistance Level | $5.37 | $1.77 |
| Average True Range (ATR) | 0.33 | 0.07 |
| MACD | -0.19 | -0.00 |
| Stochastic Oscillator | 0.82 | 38.33 |
Altimmune Inc is a clinical-stage biopharmaceutical company focused on developing treatments for obesity, metabolic diseases, and liver diseases. Its product candidate, pemvidutide (formerly known as ALT-801), is a novel, investigational, peptide-based GLP-1/glucagon dual receptor agonist. Pemvidutide is currently in clinical development for obesity and metabolic-associated steatohepatitis (MASH). The company also plans to pursue additional indications for pemvidutide that leverage the differentiated clinical profile of pemvidutide.
Service Properties Trust is a real estate investment trust that owns hotel properties. These properties are located in the United States, along with Canada and Puerto Rico. The company operates through its hotel investment unit and net lease investments. The firm derives the majority of its revenue from the hotel real estate investments unit. The hotels are distinguished between their service levels, which include full service, select service, and extended stay; and chain scale, which includes luxury, upper upscale, upscale, upper midscale, and midscale. The hotels are extended stay or upscale. Some of the hotel brands include Courtyard by Marriott, Royal Sonesta, Crowne Plaza Hotels & Resorts, and Hyatt Place.